Humana (HUM) stock has remained sideways for the year with the company lowering its full-year earnings outlook. While Humana believes that headwinds Medicare Advantage market is likely to sustain, there are factors that can trigger growth beyond the current challenges.
One possible catalyst is Humana working with Mark Cuban on a potential pharmacy partnership. The likely objective of this partnership would be to simplify the drug supply chain.
